Dynavax Technologies | Salgsomkostninger Og Administration

Selling And Administration Expenses Lave om Dato
Adma Biologics USD 16.22M 1.03M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Dynavax Technologies USD 39.79M 2.63M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Dynavax Technologies Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2024.